Abstract
Pharmacotherapy is the most common intervention for attention-deficit hyperactivity disorder (ADHD). Stimulant medications are highly efficacious and are the gold-standard for treating the inattention, impulsivity and excessive motoric activity associated with ADHD. Methylphenidate and amphetamine-based stimulants are now available in longer-acting, once-daily and shorter-acting divided dosing schedules. Several nonstimulant, second-line treatments are now available or under development for the treatment of ADHD in children and adults. This article reviews the support for a variety of pharmacological agents and the issues to be considered when selecting an agent. The authors conclude that there is a need for additional direct comparisons between the longer-acting agents to effectively guide the practicing clinician. 2004
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1313-1320 |
| Number of pages | 8 |
| Journal | Expert Opinion on Pharmacotherapy |
| Volume | 5 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 2004 |
| Externally published | Yes |
Keywords
- Attention deficit hyperactivity disorder
- Drug treatment
- Nonstimulant
- Side effects
- Stimulant
ASJC Scopus subject areas
- Pharmacology (medical)
- Pharmacology, Toxicology and Pharmaceutics(all)